Does C-reactive protein predict recurrent preeclampsia

Hypertension in Pregnancy

Volumn 29, Issue 4, 2010, Pages 399-409

  Gammill, Hilary S ^a   Powers, Robert W ^a   Clifton, Rebecca G ^b   Van Dorsten, J Peter ^c   Klebanoff, Mark A ^d   Lindheimer, Marshall D ^e   Sibai, Baha ^f   Landon, Mark B ^g   Miodovnik, Menachem ^h   Dombrowski, Mitchell ⁱ  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^g OHIO STATE UNIVERSITY   (United States)

^h UNIVERSITY OF CINCINNATI   (United States)

ⁱ WAYNE STATE UNIVERSITY   (United States)

Author keywords

Acute phase reaction; C Reactive protein; Inflammation; Preeclampsia; Pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; PLACEBO;

AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREECLAMPSIA; PREGNANCY; PROTEIN BLOOD LEVEL; RECURRENT DISEASE;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; RECURRENCE; RISK FACTORS;

EID: 77957296290     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641950903214633     Document Type: Article

References (41)

1. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989;161(5):1200-1204.
2. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180(2 Pt 1):499-506.
3. Borzychowski AM, Sargent IL, Redman CWG. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med 2006;11(5):309-316.
4. Funai EF, Friedlander Y, Paltiel O, Tiram E, Xue X, Deutsch L, et al. Long-term mortality after preeclampsia. Epidemiology 2005;16(2):206-215.
5. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. Br Med J 2001;323(7323):1213-1217.
6. Roberts JM, Gammill HS. Preeclampsia: Recent Insights. Hypertension 2005;46(6):1243-1249.
7. Tillet WS FT. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med 1930;52:561.
8. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004;351(25):2599-2610. (Pubitemid 39628581)
9. Wolf M, Kettyle E, Sandler L, Ecker JL, Roberts J, Thadhani R. Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol 2001;98(5, Part 1):757-762.
10. Belo L, Santos-Silva A, Caslake M, Cooney J, Pereira-Leite L, Quintanilha A, et al. Neutrophil activation and C-reactive protein concentration in preeclampsia. Hypertens Preg 2003;22(2):129-141.
11. Donker RB, Molema G, Faas MM, Kallenberg CGM, van Pampus MG, Timmer A, et al. Absence of in vivo generalized pro-inflammatory endothelial activation in severe, early-onset preeclampsia. J Soc Gynecol Investig 2005;12(7):518-528.
12. Ustun Y, Engin-Ustun Y, Kamaci M. Association of fibrinogen and C-reactive protein with severity of preeclampsia. Euro J Obstet Gynecol Reproduct Biol 2005;121(2):154-158.
13. Freeman DJ, McManus F, Brown EA, Cherry L, Norrie J, Ramsay JE, et al. Short-and longterm changes in plasma inflammatory markers associated with preeclampsia. [Article]. Hypertension 2004;44(5):708-714.
14. Teran E, Escudero C, Moya W, Flores M, Vallance P, Lopez-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia. Inter J Gynecol Obstet 2001;75(3):243-249.
15. Paternoster DM, Fantinato S, Stella A, Nanhorngue KN, Milani M, Plebani M, et al. C-reactive protein in hypertensive disorders in pregnancy. Clin Appl Thromb/Hemos 2006;12(3):330-337.
16. Kumru S, Godekmerdan A, Kutlu S, Ozcan Z. Correlation of maternal serum high-sensitive C-reactive protein levels with biochemical and clinical parameters in preeclampsia. Euro J Obstet Gynecol Reproduct Biol 2006;124(2):164-167.
17. Deveci K, Sogut E, Evliyaoglu O, Duras N. Pregnancy-associated plasma protein-A and C-reactive protein levels in pre-eclamptic and normotensive pregnant women at third trimester. J Obstet Gynaecol Res 2009;35(1):94-98.
18. Tjoa ML, van Vugt JMG, Go ATJJ, Blankenstein MA, Oudejans CBM, van Wijk IJ. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol 2003;59(1):29-37.
19. Savvidou MD, Lees CC, Parra M, Hingorani AD, Nicolaides KH. Levels of C-reactive protein in pregnant women who subsequently develop pre-eclampsia. BJOG: An Inter J Obstet Gynaecol 2002;109(3):297-301.
20. Qiu C, Luthy DA, Zhang C, Walsh SW, Leisenring WM, Williams MA. A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia. Am. J Hypertens 2004;17(2):154-160. (Pubitemid 38125133)
21. Garci'a RG, Celedon J, Sierra-Laguado J, Alarcon MA, Luengas C, Silva F, et al. Raised C-Reactive protein and impaired flow-mediated vasodilation precede the development of preeclampsia. Am J Hypertens 2007;20(1):98-103.
22. Djurovic S, Clausen T, Wergeland R, Brosstad F, Berg K, Henriksen T. Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia. BJOG: An Inter J Obstet Gynaecol 2002;109(7):759-764.
23. Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. N Engl J Med 1998;338(11):701-705.
24. Teran E, Escudero C, Calle A. C-reactive protein during normal pregnancy and preeclampsia. International J Gynecol Obstet 2005;89(3):2997-300.
25. Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem 2004;279(47):48487-48490.
26. Marnell L, Mold C, Du Clos TW. C-reactive protein: Ligands, receptors and role in inflammation. Clin Immunol 2005;117(2):104-111.
27. Hubel CA, Powers RW, Snaedal S, Gammill HS, Ness RB, Roberts JM, et al. C-reactive protein is elevated 30 years after eclamptic pregnancy. Hypertension 2008;51(6):1499-1505.
28. Portelinha A, Belo Ls, Tejera E, Rebelo I. Adhesion molecules (VCAM-1 and ICAM-1) and C-reactive protein in women with history of preeclampsia. Acta Obstet Gynecol Scand 2008;87(9):969-971.
29. Smith GN, Walker MC, Liu A, Wen SW, Swansburg M, Ramshaw H, et al. A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol 2009;200(1):58.e1-58.e8.
30. Sattar N, Ramsay J, Crawford L, Cheyne H, Greer IA. Classic and novel risk factor parameters in women with a history of preeclampsia. Hypertension 2003;42(1):39-42.
31. Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001;86(6):2505-2512.
32. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-{alpha}, in Vivo. J Clin Endocrinol Metab 1997;82(12):4196-4200.
33. Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-reactive protein in wealthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction-A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vascul Biol 1999;19(4):972-978.
34. Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 1998;40(2):102-111.
35. Bodnar LM, Ness RB, Harger GF, Roberts JM. Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia. Am J Epidemiol 2005;162(12):1198-1206.
36. Belo L, Santos-Silva A, Rocha S, Caslake M, Cooney J, Pereira-Leite L, et al. Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy. Euro J Obstet Gynecol Reproduct Biol 2005;123(1):46-51.
37. Bertran N, Camps J, Fernandez-Ballart J, Murphy MM, Arija V, Ferre N, et al. Evaluation of a high-sensitivity turbidimetric immunoassay for serum C-reactive protein: application to the study of longitudinal changes throughout normal pregnancy. Clin Chem Lab Med 2005;43(3):308-313.
38. Picklesimer AH, Jared HL, Moss K, Offenbacher S, Beck JD, Boggess KA. Racial differences in C-reactive protein levels during normal pregnancy. Am J Obstet Gynecol 2008;199(5):523.e1-523.e6.
39. Khera A, McGuire DK, Murphy SA, Stanek HG, Das SR, Vongpatanasin W, et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 2005;46(3):464-469.
40. Woloshin S, Schwartz LM. Distribution of C-Reactive Protein Values in the United States. N Engl J Med 2005;352(15):1611a-1613.
41. Ledue TB, Rifai N. Preanalytic and analytic sources of variations in C-reactive protein measurement: Implications for cardiovascular disease risk assessment. Clin Chem 2003;49(8):1258-1271.